 |
 |
Dick Beaumont -----Original Message----- Provided here for your convenience is the link to a new posting entitled: Health Canada reviewing link between Parkinson's drug Permax and heart valve conditions - Consumer Information Health Canada is informing Canadians that Permax, a drug used for the treatment of Parkinson's disease, has been withdrawn from the U.S. market amidst concerns about an association with cardiac valvulopathy, a condition involving inflammation or stiffening of the heart valves. http://www.hc-sc.gc.ca/ahc-asc/media/advisories-avis/2007/index_e.html ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn